Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Investors
Funding rounds
Exits
Accelerators
More organizations
Companies
Entrega Bio
Save
Entrega Bio
A proprietary technology that makes injectable substances available orally.
Launch date
2010
Employees
1 people
Market cap
-
Enterprise valuation
$20—30m
(Dealroom.co estimates Dec 2017.)
Boston Massachusetts (HQ)
http://entregabio.com
https://www.linkedin.com/company/entrega-inc-
B2B
health
hard tech
biotechnology
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Entrega Bio funding
Entrega Bio investors
Edit
Date
Investors
Amount
Round
Jan 2011
PureTech
$4.0m
Series A
Dec 2017
Eli Lilly
$5.0m
Early VC
Total Funding
$9.0m
Recent News about Entrega Bio
Edit